Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
Abstract Background The prognosis of patients with progressive or recurrent high-grade gliomas (HGGs) after surgery remains poor. Iodine-125 brachytherapy is emerging as a salvage method for the treatment of gliomas. This study aimed to investigate whether permanent iodine-125 brachytherapy could be...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2020-06-01
|
| Rangatū: | BMC Cancer |
| Ngā marau: | |
| Urunga tuihono: | http://link.springer.com/article/10.1186/s12885-020-07086-8 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|